Gene · 6041
Papers3,466
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,466
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus Lpro through Interaction with the N-Terminal Domain of Swine RNase L. | J Virol | 2021 | 33980594 | PubTator, text mining | PubMed |
| The CD8+ T Cell Noncytotoxic Antiviral Responses. | Microbiol Mol Biol Rev | 2021 | 33980586 | PubTator, text mining | PubMed |
| Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside. | ACS Biomater Sci Eng | 2021 | 33979143 | PubTator, text mining | PubMed |
| Genetic predisposition in the 2'-5'A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity. | Diabetologia | 2021 | 33973017 | PubTator, text mining | PubMed |
| MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets. | Front Oncol | 2021 | 33968718 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. | Prostate | 2021 | 33956343 | PubTator, text mining | PubMed |
| Innate immune sensing of coronavirus and viral evasion strategies. | Exp Mol Med | 2021 | 33953325 | PubTator, text mining | PubMed |
| Type I and III interferon responses in SARS-CoV-2 infection. | Exp Mol Med | 2021 | 33953323 | PubTator, text mining | PubMed |
| Research Progress of Circular RNA in Gastrointestinal Tumors. | Front Oncol | 2021 | 33937077 | PubTator, text mining | PubMed |
| Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. | Arch Virol | 2021 | 33934196 | PubTator, text mining | PubMed |
| Promising role of defensins peptides as therapeutics to combat against viral infection. | Microb Pathog | 2021 | 33933603 | PubTator, text mining | PubMed |
| Programmable technologies to manipulate gene expression at the RNA level. | Curr Opin Chem Biol | 2021 | 33930627 | PubTator, text mining | PubMed |
| Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures. | Viruses | 2021 | 33925004 | PubTator, text mining | PubMed |
| Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients. | J Pers Med | 2021 | 33924671 | PubTator, text mining | PubMed |
| Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes. | Biomolecules | 2021 | 33922087 | PubTator, text mining | PubMed |
| Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs. | Int J Mol Sci | 2021 | 33921888 | PubTator, text mining | PubMed |
| A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications. | Int J Mol Sci | 2021 | 33919834 | PubTator, text mining | PubMed |
| Type I Interferon Production of Plasmacytoid Dendritic Cells under Control. | Int J Mol Sci | 2021 | 33919546 | PubTator, text mining | PubMed |
| Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. | Cells | 2021 | 33917481 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6041/papers?page=51